Hep C treatment and liver cancer survival
Hepatitis C virus can lead to severe liver damage and hepatocellular carcinoma (HCC), a common corm of liver cancer. Researchers have long known that early detection and treatment of hepatitis C with direct-acting antiviral therapy (DAAs) can reduce the risks of developing HCC. Now there appears to be even more good news. Patients who have liver cancer and are cured of hepatitis c have improved survival rates. This suggests that patients with severe liver damage from HCV may still see benefits from treatment.
Read more here.
Learn more about the study that led these findings here.